Considering the body weight reduction of more than 10% and the significant improvement in glycemic parameters without an increased risk of hypoglycemia, this trial establishes the efficacy and safety of the 7.2 mg dose of semaglutide compared with placebo in adults with obesity and type 2 diabetes, Lingvay and colleagues wrote.
The Science Behind the Shot: These peptides mimic a naturally occurring hormone in your body, which helps regulate blood sugar and appetite, which slows down digestion, making you feel fuller for longer
"I find it so inspiring to witness others achieve their health and wellness goals
Descriptive statistics with mean and 95% confidence interval as well as median and interquartile range were used for continuous variables
Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter Phase II trial
Convenience and Compliance: Semaglutide is administered as a once-weekly injection, making it a convenient option for those with busy lifestyles
